Mark Lappe

Mark co-founded Inhibrx with Brendan Eckelman and Quinn Deveraux in 2010 and has served as its Chief Executive Officer and Chief Financial Officer since the company’s inception. Mark also serves as the Chairman of Inhibrx’s Board of Directors. Mark has extensive expertise in the biotechnology industry with over thirty years of experience in executive management, investment management and executive recruiting, having built the executive teams of over forty start-up biotechnology and medical device companies. Prior to founding Inhibrx, Mark was the founder and Managing Partner of Efficacy Biotech Fund, a fund focused on strategic investment in public biotechnology companies.